GLF
AZN icon

Groupe la Francaise’s AstraZeneca AZN Stock Holding History

Groupe la Francaise’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$191M Buy
+984,608
New +$190M 2.62% 8
2025
Q4 		– Sell
-65
Closed -$8.21K – 487
2025
Q3 		$8.21K Buy
+65
New +$9.84K ﹤0.01% 585

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $148B AUM

Groupe la Francaise's AZN Position: Q1 2026 in Review

Groupe la Francaise opened a new position in AstraZeneca (AZN) in Q1 2026: 984,608 shares worth $191M. The stake represents 2.62% of the portfolio and ranks #8 among its holdings. This is a return to the name: Groupe la Francaise previously reported a position in AZN as recently as Q3 2025.

Groupe la Francaise first reported a position in AZN in Q3 2025 and has held it in 2 quarters since. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Groupe la Francaise held 984,608 shares of AstraZeneca worth $191M as of Q1 2026.
  • AstraZeneca was a new Groupe la Francaise position in Q1 2026.
  • AstraZeneca made up 2.62% of Groupe la Francaise's portfolio in Q1 2026, its #8 holding.
  • Groupe la Francaise first reported a position in AstraZeneca in Q3 2025 and has held it in 2 quarters since.
  • 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Groupe la Francaise's 13F filing for Q1 2026, filed 21 May 2026.